Medtech

This tool can determine risk for acute respiratory distress syndrome, the fluid build-up in the lungs, with up to 80% accuracy.

Chinese tech companies aim to share their experience and solutions while attracting overseas users.

The medtech startup reports near three-fold user growth since start of the COVID-19 crisis.

The Chinese super app joins other tech giants looking to develop new software to fight the coronavirus pandemic.

The firm will use the fresh capital for product development and expansion.

Niramai’s radiation-free, noninvasive tech detects malignancies in 15 minutes.

The fund is being deployed into seed-stage opportunities in the business-to-business sector across Southeast Asia, India, and Japan.

China named its first team of national AI champions in 2017, tasking them to develop the technology for uses including health care.